<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2023.1265790</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Development and validation of machine-learning models for the difficulty of retroperitoneal laparoscopic adrenalectomy based on radiomics</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Sun</surname><given-names>Shiwei</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1918331"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Yao</surname><given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2389853"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname><given-names>Yue</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2058202"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yue</surname><given-names>Peng</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guo</surname><given-names>Fuyu</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname><given-names>Xiaoqian</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2393584"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname><given-names>Yangang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital</institution>, <addr-line>Taiyuan</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University</institution>, <addr-line>Taiyuan</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology</institution>, <addr-line>Wuhan</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Marta Araujo-Castro, Ram&#xf3;n y Cajal University Hospital, Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jingshan Gong, Jinan University, China; Davide De Sio, Catholic University of the Sacred Heart, Italy</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Yangang Zhang, <email xlink:href="mailto:urozyg@163.com">urozyg@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn002">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>11</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1265790</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>11</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Sun, Yao, Wang, Yue, Guo, Deng and Zhang</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Sun, Yao, Wang, Yue, Guo, Deng and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>The aim is to construct machine learning (ML) prediction models for the difficulty of retroperitoneal laparoscopic adrenalectomy (RPLA) based on clinical and radiomic characteristics and to validate the models.</p>
</sec>
<sec>
<title>Methods</title>
<p>Patients who had undergone RPLA at Shanxi Bethune Hospital between August 2014 and December 2020 were retrospectively gathered. They were then randomly split into a training set and a validation set, maintaining a ratio of 7:3. The model was constructed using the training set and validated using the validation set. Furthermore, a total of 117 patients were gathered between January and December 2021 to form a prospective set for validation. Radiomic features were extracted by drawing the region of interest using the 3D slicer image computing platform and Python. Key features were selected through LASSO, and the radiomics score (Rad-score) was calculated. Various ML models were constructed by combining Rad-score with clinical characteristics. The optimal models were selected based on precision, recall, the area under the curve, F1 score, calibration curve, receiver operating characteristic curve, and decision curve analysis in the training, validation, and prospective sets. Shapley Additive exPlanations (SHAP) was used to demonstrate the impact of each variable in the respective models.</p>
</sec>
<sec>
<title>Results</title>
<p>After comparing the performance of 7 ML models in the training, validation, and prospective sets, it was found that the RF model had a more stable predictive performance, while xGBoost can significantly benefit patients. According to SHAP, the variable importance of the two models is similar, and both can reflect that the Rad-score has the most significant impact. At the same time, clinical characteristics such as hemoglobin, age, body mass index, gender, and diabetes mellitus also influenced the difficulty.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>This study constructed ML models for predicting the difficulty of RPLA by combining clinical and radiomic characteristics. The models can help surgeons evaluate surgical difficulty, reduce risks, and improve patient benefits.</p>
</sec>
</abstract>
<kwd-group>
<kwd>adrenal tumor</kwd>
<kwd>laparoscopy</kwd>
<kwd>retroperitoneal space</kwd>
<kwd>machine learning</kwd>
<kwd>radiomics</kwd>
<kwd>random forest</kwd>
<kwd>extreme gradient boosting</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="35"/>
<page-count count="12"/>
<word-count count="4016"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Adrenal Endocrinology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Adrenal tumors (ATs) are a rare type of tumor that usually occurs in the cortex or medulla of the adrenal gland (<xref ref-type="bibr" rid="B1">1</xref>). Depending on their type and size, these tumors can be benign or malignant (<xref ref-type="bibr" rid="B2">2</xref>). ATs can cause many symptoms, including high blood pressure, palpitations, headaches, insomnia, anxiety, and obesity (<xref ref-type="bibr" rid="B3">3</xref>). In some cases, these symptoms may be mistaken for symptoms of other diseases, so further testing is needed to determine the diagnosis (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>Treatment for AT includes surgery, radiation therapy, and chemotherapy. Surgery is the most common treatment method and can altogether remove the tumor (<xref ref-type="bibr" rid="B7">7</xref>). The gold standard treatment for AT is laparoscopic surgery, which can be divided into two main approaches: transperitoneal laparoscopic adrenalectomy (TPLA) and retroperitoneal laparoscopic adrenalectomy (RPLA) (<xref ref-type="bibr" rid="B8">8</xref>). The RPLA involves entering the retroperitoneal cavity through laparoscopic surgery, avoiding interference with abdominal organs, and reducing surgical trauma and recovery time. Compared with traditional open surgery, this technique has fewer complications and faster recovery (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>In the field of medicine, machine learning (ML) has wide-ranging applications (<xref ref-type="bibr" rid="B3">3</xref>). For example, ML can be used for medical image recognition to help doctors diagnose diseases. It can also be used to predict the health status of patients, assisting doctors to develop better treatment plans. In addition, ML can be used for drug development and clinical trials to speed up the development and launch of new drugs (<xref ref-type="bibr" rid="B11">11</xref>). For example, a study has used ML to differentiate between adrenal pheochromocytoma and adrenocortical adenoma (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>Radiomics is an emerging field of medicine that combines computer science, mathematics, and medical imaging to understand better and diagnose diseases (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Radiomics analyzes large amounts of medical imaging data to extract useful information, helping doctors make more accurate diagnoses and treatment decisions (<xref ref-type="bibr" rid="B15">15</xref>).</p>
<p>This study aimed to collect data retrospectively from patients with AT who underwent RPLA at Shanxi Bethune Hospital from August 2014 to December 2020. The study utilized ML to analyze their clinical and radiomics features and develop a predictive model for the difficulty of RPLA. The goal was to improve preoperative preparation, reduce surgical risks, and enhance patient benefits.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Method</title>
<sec id="s2_1">
<label>2.1</label>
<title>General information</title>
<p>We retrospectively collected data from patients with AT treated at Shanxi Bethune Hospital between August 2014 and December 2020.&#xa0;A model was established using this data and prospectively validated with AT patients treated from January 2021 to December 2021. Inclusion criteria: 1) abdominal Computed Tomography (CT) examination confirming the presence of an AT within 15 days before surgery, 2) preoperative routine laboratory tests to determine the hormonal activity of AT, and 3) treatment of AT with laparoscopic surgery. Exclusion criteria: 1) patients who did not undergo surgery, 2) patients who underwent multiple surgeries concurrently, 3) patients treated for AT with other surgical methods, and 4) patients with incomplete preoperative radiological examination. A total of 396 patients were included in the study, and an additional 117 patients were collected for prospective validation (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>). All surgical procedures are performed by a cohesive team within the same department at a single center, led by an expert surgeon with 35 years of experience.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The process of this study. (<bold>A</bold> Flowchart of this study; <bold>(B)</bold> Original CT images; <bold>(C)</bold> Drawing of regions of interest [ROIs]; <bold>(D)</bold> 3D reconstruction of the ROIs; <bold>(E)</bold> Venn plot of the reasons for the difficulty of surgery).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1265790-g001.tif"/>
</fig>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Research method</title>
<p>Referring to previous studies (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>) and combining practical experience, we defined cases with serious surgical difficulty if any of the following conditions were met: 1) operation time &#x2265; P<sub>75</sub> (150&#xa0;min), 2) intraoperative injury to organs or vessels requiring blood transfusion, 3) conversion from minimally invasive to open surgery, 4) postoperative complications of Clavien-Dindo classification (<xref ref-type="bibr" rid="B21">21</xref>) greater than or equal to grade 3, 5) Postoperative hospital stay &#x2265; P<sub>95</sub> (15 days).</p>
<p>The Siemens Somatom Definition Flash or Force dual-source CT scanner (manufactured by Siemens AG in Munich, Germany) was utilized for the purpose of scanning and reconstructing thin-slice images. DICOM format was used to export the images. Using the 3D Slicer image computing platform (version 5. 0. 2), two radiology-trained urologists independently identified the region of interest (ROI) in arterial-enhanced images. Python 3. 7. 1 (Python Software Foundation) was utilized to extract radiomics features from the images (<xref ref-type="fig" rid="f1"><bold>Figures&#xa0;1B&#x2013;D</bold></xref>). The included image types are Original, Wavelet, Laplacian of Gaussian, Square, Square Root, Logarithm, Exponential, Gradient, Local Binary Pattern 2D, and Local Binary Pattern 3D. The feature types consisted of First Order Features, Shape Features (3D), Shape Features (2D), Gray Level Co-occurrence Matrix (GLCM) Features, Gray Level Size Zone Matrix (GLSZM) Features, Gray Level Run Length Matrix (GLRLM) Features, Neighboring Gray Tone Difference Matrix (NGTDM) Features, Gray Level Dependence Matrix (GLDM) Feature. A total of 1967 radiomics features were extracted (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>). Data on patients&#x2019; clinical conditions and treatment were obtained from the computerized physician order entry and medical record management system (Winning Health Technology Group Co., Ltd., Shanghai, China).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Radiomic features selected by LASSO. (<bold>A</bold> 10-fold cross-validation corresponding AUC results; <bold>(B)</bold> 279 feature screening adjoint coefficient changes).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1265790-g002.tif"/>
</fig>
<p>Patients were randomly divided into a training set and a validation set at a ratio of 7:3. The training set was used for model construction, and the validation set was used for model validation.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Statistical methods</title>
<p>Data were further analyzed using R 4. 2. 3 (Vienna Statistical Computing Foundation, Austria). All continuous variables were non-normally distributed and were presented as median [interquartile range]; categorical variables were presented as frequency and percentage (%). Analysis of variance (ANOVA) was used to compare differences between sets in the training set, validation set, and prospective set. The consistency of the regions of interest (ROIs) drawn by the two urologists was evaluated using the intraclass correlation coefficient (ICC), excluding features with a correlation below 0. 75. Radiomics features were subjected to univariable logistic regression analysis using the &#x201c;glmnet&#x201d; package. Factors with a P-value greater than 0. 05 were considered unrelated and subsequently excluded. Key features were selected using the Least Absolute Shrinkage and Selection Operator (LASSO), and the radiomics score (Rad-score) was calculated based on the results. Using the &#x201c;mlr3&#x201d; package, seven ML models were developed by combining the Rad-score with clinical characteristics. These models included Classification and Regression Trees (CART), K-Nearest Neighbors (KNN), LASSO, Naive Bayes (NB), Random Forest (RF), Support Vector Machine (SVM), and Extreme Gradient Boosting (xGBoost). The optimal models were selected based on precision, recall, area under the curve (AUC), F1 score, calibration curve, Receiver Operating Characteristic (ROC) curve, and decision curve analysis (DCA) in the training set, validation set, and prospective set. Shapley Additive exPlanations (SHAP) value demonstrated the impact of each variable in the respective model (<xref ref-type="bibr" rid="B22">22</xref>).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>General information</title>
<p>A total of 396 patients were included in the study. Patients were randomly divided into a training set and a validation set at a ratio of 7:3. Baseline patient characteristics are shown in <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>.&#xa0;A total of 130 patients were considered to have high surgical difficulty due to meeting one or more criteria, with specific reasons shown in <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1E</bold></xref>. An additional 117 patients were collected and regarded as a prospective set. ANOVA showed no statistically significant differences in baseline characteristics between sets.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Baseline clinical and radiomics characteristics of patients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Characteristics</th>
<th valign="top" align="center">Training set</th>
<th valign="top" align="center">Validation set</th>
<th valign="top" align="center">Prospective set</th>
<th valign="top" align="center">F</th>
<th valign="top" align="center">P</th>
</tr>    <tr>
<th valign="top" align="center">Radiomics characteristics</th>
<th valign="top" align="left"/>
<th valign="top" align="left"/>
<th valign="top" align="left"/>
<th valign="top" align="left"/>
<th valign="top" align="left"/>
</tr>
<tr>
<th valign="top" align="center">Rad score</th>
<th valign="top" align="center">8.87[8.76,9.00]</th>
<th valign="top" align="center">8.87[8.74,8.97]</th>
<th valign="top" align="center">8.87[8.77,8.97]</th>
<th valign="top" align="center">1.030</th>
<th valign="top" align="center">0.358</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" align="left" colspan="6">Clinical characteristics</th>
</tr>
<tr>
<th valign="top" align="left" colspan="6">Preoperative</th>
</tr>
<tr>
<td valign="top" align="left">Gender</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.732</td>
<td valign="top" align="center">0.482</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Male</td>
<td valign="top" align="center">125(45.1)</td>
<td valign="top" align="center">53(44.5)</td>
<td valign="top" align="center">60(51.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Female</td>
<td valign="top" align="center">152(54.9)</td>
<td valign="top" align="center">66(55.5)</td>
<td valign="top" align="center">57(48.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Age (year)</td>
<td valign="top" align="center">50.00[40.00,59.00]</td>
<td valign="top" align="center">51.00[42.00,58.00]</td>
<td valign="top" align="center">51.00[39.00,58.00]</td>
<td valign="top" align="center">0.047</td>
<td valign="top" align="center">0.954</td>
</tr>
<tr>
<td valign="top" align="left">BMI (kg/m<sup>2</sup>)</td>
<td valign="top" align="center">24.72[22.68,27.51]</td>
<td valign="top" align="center">24.57[23.10,27.36]</td>
<td valign="top" align="center">25.95[23.44,28.32]</td>
<td valign="top" align="center">2.430</td>
<td valign="top" align="center">0.089</td>
</tr>
<tr>
<td valign="top" align="left">Side</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1.130</td>
<td valign="top" align="center">0.324</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Left</td>
<td valign="top" align="center">161(58.1)</td>
<td valign="top" align="center">77(64.7)</td>
<td valign="top" align="center">65(55.6)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Right</td>
<td valign="top" align="center">116(41.9)</td>
<td valign="top" align="center">42(35.3)</td>
<td valign="top" align="center">52(44.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Hypertension</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.417</td>
<td valign="top" align="center">0.660</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">58(20.9)</td>
<td valign="top" align="center">27(22.7)</td>
<td valign="top" align="center">21(17.9)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">219(79.1)</td>
<td valign="top" align="center">92(77.3)</td>
<td valign="top" align="center">96(82.1)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Diabetes mellitus</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1.446</td>
<td valign="top" align="center">0.236</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">229(82.7)</td>
<td valign="top" align="center">92(77.3)</td>
<td valign="top" align="center">89(76.1)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">48(17.3)</td>
<td valign="top" align="center">27(22.7)</td>
<td valign="top" align="center">28(23.9)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Scoliosis</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1.108</td>
<td valign="top" align="center">0.331</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">264(95.3)</td>
<td valign="top" align="center">113(95.0)</td>
<td valign="top" align="center">115(98.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">13(4.7)</td>
<td valign="top" align="center">6(5.0)</td>
<td valign="top" align="center">2(1.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Coronary disease</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1.673</td>
<td valign="top" align="center">0.189</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">249(89.9)</td>
<td valign="top" align="center">107(89.9)</td>
<td valign="top" align="center">98(83.8)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">28(10.1)</td>
<td valign="top" align="center">12(10.1)</td>
<td valign="top" align="center">19(16.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Cerebral infarction</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.965</td>
<td valign="top" align="center">0.382</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">254(91.7)</td>
<td valign="top" align="center">104(87.4)</td>
<td valign="top" align="center">107(91.5)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">23(8.3)</td>
<td valign="top" align="center">15(12.6)</td>
<td valign="top" align="center">10(8.5)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Hyperlipidemia</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.393</td>
<td valign="top" align="center">0.675</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">245(88.4)</td>
<td valign="top" align="center">108(90.8)</td>
<td valign="top" align="center">102(87.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">32(11.6)</td>
<td valign="top" align="center">11(9.2)</td>
<td valign="top" align="center">15(12.8)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">History of malignancy</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">2.129</td>
<td valign="top" align="center">0.120</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">270(97.5)</td>
<td valign="top" align="center">113(95.0)</td>
<td valign="top" align="center">109(93.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">7(2.5)</td>
<td valign="top" align="center">6(5.0)</td>
<td valign="top" align="center">8(6.8)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">History of operation</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.436</td>
<td valign="top" align="center">0.647</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">202(72.9)</td>
<td valign="top" align="center">84(70.6)</td>
<td valign="top" align="center">80(68.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">75(27.1)</td>
<td valign="top" align="center">35(29.4)</td>
<td valign="top" align="center">37(31.6)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Infectious disease</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.262</td>
<td valign="top" align="center">0.769</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">272(98.2)</td>
<td valign="top" align="center">118(99.2)</td>
<td valign="top" align="center">115(98.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">5(1.8)</td>
<td valign="top" align="center">1(0.8)</td>
<td valign="top" align="center">2(1.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Previous antiplatelet use</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">2.567</td>
<td valign="top" align="center">0.078</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">268(96.8)</td>
<td valign="top" align="center">116(97.5)</td>
<td valign="top" align="center">108(92.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">9(3.2)</td>
<td valign="top" align="center">3(2.5)</td>
<td valign="top" align="center">9(7.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Hb (g/L)</td>
<td valign="top" align="center">137.0[126.0,145.0]</td>
<td valign="top" align="center">138.0[127.5,147.0]</td>
<td valign="top" align="center">137.0[127.0,146.0]</td>
<td valign="top" align="center">0.065</td>
<td valign="top" align="center">0.937</td>
</tr>
<tr>
<th valign="top" colspan="6" align="left">Intraoperative and postoperative</th>
</tr>
<tr>
<td valign="top" align="left">Range</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.475</td>
<td valign="top" align="center">0.622</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Partial</td>
<td valign="top" align="center">253(91.3)</td>
<td valign="top" align="center">105(88.2)</td>
<td valign="top" align="center">105(89.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Radical</td>
<td valign="top" align="center">24(8.7)</td>
<td valign="top" align="center">14(11.8)</td>
<td valign="top" align="center">12(10.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Operation time (min)</td>
<td valign="top" align="center">110.0[90.0,150.0]</td>
<td valign="top" align="center">110.0[90.0,149.0]</td>
<td valign="top" align="center">98.0[76.0,130.0]</td>
<td valign="top" align="center">4.130</td>
<td valign="top" align="center">0.017</td>
</tr>
<tr>
<td valign="top" align="left">Blood loss (ml)</td>
<td valign="top" align="center">20.0[0.0,50.0]</td>
<td valign="top" align="center">20.0[0.0,50.0]</td>
<td valign="top" align="center">15.0[0.0,25.0]</td>
<td valign="top" align="center">0.264</td>
<td valign="top" align="center">0.768</td>
</tr>
<tr>
<td valign="top" align="left">POHS</td>
<td valign="top" align="center">8.0[6.0,9.0]</td>
<td valign="top" align="center">7.0[6.5,9.0]</td>
<td valign="top" align="center">6.0[2.0,7.0]</td>
<td valign="top" align="center">15.966</td>
<td valign="top" align="center">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Conversion</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.558</td>
<td valign="top" align="center">0.573</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">273(98.6)</td>
<td valign="top" align="center">116(97.5)</td>
<td valign="top" align="center">116(99.1)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">4(1.4)</td>
<td valign="top" align="center">3(2.5)</td>
<td valign="top" align="center">1(0.9)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Transfusion</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.078</td>
<td valign="top" align="center">0.925</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;No</td>
<td valign="top" align="center">268(96.8)</td>
<td valign="top" align="center">115(96.6)</td>
<td valign="top" align="center">114(97.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Yes</td>
<td valign="top" align="center">9(3.2)</td>
<td valign="top" align="center">4(3.4)</td>
<td valign="top" align="center">3(2.6)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Complications</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.122</td>
<td valign="top" align="center">0.885</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;None</td>
<td valign="top" align="center">248(89.5)</td>
<td valign="top" align="center">107(89.9)</td>
<td valign="top" align="center">105(89.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;1</td>
<td valign="top" align="center">9(3.2)</td>
<td valign="top" align="center">2(1.7)</td>
<td valign="top" align="center">4(3.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;2</td>
<td valign="top" align="center">2(0.7)</td>
<td valign="top" align="center">1(0.8)</td>
<td valign="top" align="center">0(0.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;3a</td>
<td valign="top" align="center">1(0.4)</td>
<td valign="top" align="center">0(0.0)</td>
<td valign="top" align="center">3(2.6)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;3b</td>
<td valign="top" align="center">0(0.0)</td>
<td valign="top" align="center">1(0.8)</td>
<td valign="top" align="center">0(0.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;4</td>
<td valign="top" align="center">17(6.1)</td>
<td valign="top" align="center">8(6.7)</td>
<td valign="top" align="center">5(4.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Pathology</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1.330</td>
<td valign="top" align="center">0.265</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;NFAT</td>
<td valign="top" align="center">107(38.6)</td>
<td valign="top" align="center">51(42.9)</td>
<td valign="top" align="center">38(32.5)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Aldosteronoma</td>
<td valign="top" align="center">79(28.5)</td>
<td valign="top" align="center">33(27.7)</td>
<td valign="top" align="center">43(36.8)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Cushing&#x2019;s syndrome</td>
<td valign="top" align="center">25(9.0)</td>
<td valign="top" align="center">16(13.4)</td>
<td valign="top" align="center">17(14.5)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Paraganglioma</td>
<td valign="top" align="center">26(9.4)</td>
<td valign="top" align="center">7(5.9)</td>
<td valign="top" align="center">7(6.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Myelolipoma</td>
<td valign="top" align="center">10(3.6)</td>
<td valign="top" align="center">5(4.2)</td>
<td valign="top" align="center">4(3.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Cyst</td>
<td valign="top" align="center">13(4.7)</td>
<td valign="top" align="center">3(2.5)</td>
<td valign="top" align="center">3(2.6)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Malignant tumor</td>
<td valign="top" align="center">5(1.8)</td>
<td valign="top" align="center">1(0.8)</td>
<td valign="top" align="center">2(1.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Ganglioneuroma</td>
<td valign="top" align="center">2(0.7)</td>
<td valign="top" align="center">2(1.7)</td>
<td valign="top" align="center">2(1.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Others</td>
<td valign="top" align="center">10(3.6)</td>
<td valign="top" align="center">1(0.8)</td>
<td valign="top" align="center">1(0.9)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>BMI, body mass index; NFAT, non-function adrenal tumor; Others(pathology) include eosinophil tumor, teratoma, schwannoma, hematoma, tuberculoma, foreign body granuloma, retroperitoneal bronchial cyst, hemangioma.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Radiomics feature selection</title>
<p>Consistency was assessed using ICC, excluding 619 radiomics features with consistency lower than 0.75 to eliminate the interference of human factors on the model. Univariable logistic analysis was performed, excluding 1069 variables with P &gt; 0.05. The remaining 279 features underwent dimensionality reduction using LASSO and ten-fold cross-validation. As the logarithm of the harmonic parameter (&#x3bb;) changed on the horizontal axis, the AUC on the vertical axis also changed. The corresponding number of selected variables is shown in <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2A</bold></xref>. A risk factor classifier was constructed using LASSO (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>), with 18 features selected (<xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>). The optimal &#x3bb; value was 0.0173, with a logarithm of -4.055.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Comparison of machine learning model performance.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Model</th>
<th valign="top" align="center">Set</th>
<th valign="top" align="center">AUC</th>
<th valign="top" align="center">Sensitivity</th>
<th valign="top" align="center">Specificity</th>
<th valign="top" align="center">Precision</th>
<th valign="top" align="left">F1-score</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">CART</td>
<td valign="top" align="center">Training</td>
<td valign="top" align="center">0.866</td>
<td valign="top" align="center">0.667</td>
<td valign="top" align="center">0.901</td>
<td valign="top" align="center">0.780</td>
<td valign="top" align="center">0.719</td>
</tr>
<tr>
<td valign="top" align="center">CART</td>
<td valign="top" align="center">Validation</td>
<td valign="top" align="center">0.421</td>
<td valign="top" align="center">0.235</td>
<td valign="top" align="center">0.776</td>
<td valign="top" align="center">0.296</td>
<td valign="top" align="center">0.262</td>
</tr>
<tr>
<td valign="top" align="center">CART</td>
<td valign="top" align="center">Prospective</td>
<td valign="top" align="center">0.356</td>
<td valign="top" align="center">0.393</td>
<td valign="top" align="center">0.809</td>
<td valign="top" align="center">0.393</td>
<td valign="top" align="center">0.393</td>
</tr>
<tr>
<td valign="top" align="center">KNN</td>
<td valign="top" align="center">Training</td>
<td valign="top" align="center">0.983</td>
<td valign="top" align="center">0.698</td>
<td valign="top" align="center">0.978</td>
<td valign="top" align="center">0.944</td>
<td valign="top" align="center">0.802</td>
</tr>
<tr>
<td valign="top" align="center">KNN</td>
<td valign="top" align="center">Validation</td>
<td valign="top" align="center">0.579</td>
<td valign="top" align="center">0.147</td>
<td valign="top" align="center">0.835</td>
<td valign="top" align="center">0.263</td>
<td valign="top" align="center">0.189</td>
</tr>
<tr>
<td valign="top" align="center">KNN</td>
<td valign="top" align="center">Prospective</td>
<td valign="top" align="center">0.588</td>
<td valign="top" align="center">0.286</td>
<td valign="top" align="center">0.798</td>
<td valign="top" align="center">0.308</td>
<td valign="top" align="center">0.296</td>
</tr>
<tr>
<td valign="top" align="center">LASSO</td>
<td valign="top" align="center">Training</td>
<td valign="top" align="center">0.824</td>
<td valign="top" align="center">0.417</td>
<td valign="top" align="center">0.956</td>
<td valign="top" align="center">0.833</td>
<td valign="top" align="center">0.556</td>
</tr>
<tr>
<td valign="top" align="center">LASSO</td>
<td valign="top" align="center">Validation</td>
<td valign="top" align="center">0.631</td>
<td valign="top" align="center">0.294</td>
<td valign="top" align="center">0.918</td>
<td valign="top" align="center">0.588</td>
<td valign="top" align="center">0.392</td>
</tr>
<tr>
<td valign="top" align="center">LASSO</td>
<td valign="top" align="center">Prospective</td>
<td valign="top" align="center">0.720</td>
<td valign="top" align="center">0.321</td>
<td valign="top" align="center">0.921</td>
<td valign="top" align="center">0.562</td>
<td valign="top" align="center">0.409</td>
</tr>
<tr>
<td valign="top" align="center">NB</td>
<td valign="top" align="center">Training</td>
<td valign="top" align="center">0.779</td>
<td valign="top" align="center">0.458</td>
<td valign="top" align="center">0.834</td>
<td valign="top" align="center">0.595</td>
<td valign="top" align="center">0.518</td>
</tr>
<tr>
<td valign="top" align="center">NB</td>
<td valign="top" align="center">Validation</td>
<td valign="top" align="center">0.696</td>
<td valign="top" align="center">0.441</td>
<td valign="top" align="center">0.776</td>
<td valign="top" align="center">0.441</td>
<td valign="top" align="center">0.441</td>
</tr>
<tr>
<td valign="top" align="center">NB</td>
<td valign="top" align="center">Prospective</td>
<td valign="top" align="center">0.662</td>
<td valign="top" align="center">0.536</td>
<td valign="top" align="center">0.730</td>
<td valign="top" align="center">0.385</td>
<td valign="top" align="center">0.448</td>
</tr>
<tr>
<td valign="top" align="center">RF</td>
<td valign="top" align="center">Training</td>
<td valign="top" align="center">0.994</td>
<td valign="top" align="center">0.885</td>
<td valign="top" align="center">0.994</td>
<td valign="top" align="center">0.988</td>
<td valign="top" align="center">0.934</td>
</tr>
<tr>
<td valign="top" align="center">RF</td>
<td valign="top" align="center">Validation</td>
<td valign="top" align="center">0.681</td>
<td valign="top" align="center">0.353</td>
<td valign="top" align="center">0.835</td>
<td valign="top" align="center">0.462</td>
<td valign="top" align="center">0.400</td>
</tr>
<tr>
<td valign="top" align="center">RF</td>
<td valign="top" align="center">Prospective</td>
<td valign="top" align="center">0.724</td>
<td valign="top" align="center">0.536</td>
<td valign="top" align="center">0.820</td>
<td valign="top" align="center">0.484</td>
<td valign="top" align="center">0.508</td>
</tr>
<tr>
<td valign="top" align="center">SVM</td>
<td valign="top" align="center">Training</td>
<td valign="top" align="center">0.917</td>
<td valign="top" align="center">0.688</td>
<td valign="top" align="center">0.950</td>
<td valign="top" align="center">0.880</td>
<td valign="top" align="center">0.772</td>
</tr>
<tr>
<td valign="top" align="center">SVM</td>
<td valign="top" align="center">Validation</td>
<td valign="top" align="center">0.677</td>
<td valign="top" align="center">0.294</td>
<td valign="top" align="center">0.847</td>
<td valign="top" align="center">0.435</td>
<td valign="top" align="center">0.351</td>
</tr>
<tr>
<td valign="top" align="center">SVM</td>
<td valign="top" align="center">Prospective</td>
<td valign="top" align="center">0.617</td>
<td valign="top" align="center">0.286</td>
<td valign="top" align="center">0.775</td>
<td valign="top" align="center">0.286</td>
<td valign="top" align="center">0.286</td>
</tr>
<tr>
<td valign="top" align="center">xGBoost</td>
<td valign="top" align="center">Training</td>
<td valign="top" align="center">0.914</td>
<td valign="top" align="center">0.750</td>
<td valign="top" align="center">0.917</td>
<td valign="top" align="center">0.828</td>
<td valign="top" align="center">0.787</td>
</tr>
<tr>
<td valign="top" align="center">xGBoost</td>
<td valign="top" align="center">Validation</td>
<td valign="top" align="center">0.615</td>
<td valign="top" align="center">0.353</td>
<td valign="top" align="center">0.706</td>
<td valign="top" align="center">0.324</td>
<td valign="top" align="center">0.338</td>
</tr>
<tr>
<td valign="top" align="center">xGBoost</td>
<td valign="top" align="center">Prospective</td>
<td valign="top" align="center">0.710</td>
<td valign="top" align="center">0.500</td>
<td valign="top" align="center">0.764</td>
<td valign="top" align="center">0.400</td>
<td valign="top" align="center">0.444</td>
</tr>
<tr>
<td valign="top" align="center">Clinical</td>
<td valign="top" align="center">Training</td>
<td valign="top" align="center">0.660</td>
<td valign="top" align="center">0.719</td>
<td valign="top" align="center">0.514</td>
<td valign="top" align="center">0.439</td>
<td valign="top" align="center">0.545</td>
</tr>
<tr>
<td valign="top" align="center">Clinical</td>
<td valign="top" align="center">Validation</td>
<td valign="top" align="center">0.621</td>
<td valign="top" align="center">0.735</td>
<td valign="top" align="center">0.431</td>
<td valign="top" align="center">0.357</td>
<td valign="top" align="center">0.481</td>
</tr>
<tr>
<td valign="top" align="center">Clinical</td>
<td valign="top" align="center">Prospective</td>
<td valign="top" align="center">0.658</td>
<td valign="top" align="center">0.821</td>
<td valign="top" align="center">0.461</td>
<td valign="top" align="center">0.324</td>
<td valign="top" align="center">0.465</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Based on the LASSO results (<xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref>), Rad-score was calculated. The specific calculation formula is provided in the <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Data</bold></xref><bold>.</bold>
</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Radiomic features selected by LASSO.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Image types</th>
<th valign="top" align="center">Feather types</th>
<th valign="top" align="center">Feathers</th>
<th valign="top" align="left">Coefficients</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">Logarithm</td>
<td valign="top" align="center">GLCM</td>
<td valign="top" align="center">Imc1</td>
<td valign="top" align="center">-0.197</td>
</tr>
<tr>
<td valign="top" align="center">Square</td>
<td valign="top" align="center">GLSZM</td>
<td valign="top" align="center">SizeZoneNonUniformityNormalized</td>
<td valign="top" align="center">-0.134</td>
</tr>
<tr>
<td valign="top" align="center">Wavelet.LLH</td>
<td valign="top" align="center">Firstorder</td>
<td valign="top" align="center">Mean</td>
<td valign="top" align="center">-0.060</td>
</tr>
<tr>
<td valign="top" align="center">Wavelet.LLL</td>
<td valign="top" align="center">Firstorder</td>
<td valign="top" align="center">Kurtosis</td>
<td valign="top" align="center">-0.049</td>
</tr>
<tr>
<td valign="top" align="center">Original</td>
<td valign="top" align="center">GLSZM</td>
<td valign="top" align="center">SizeZoneNonUniformityNormalized</td>
<td valign="top" align="center">-0.034</td>
</tr>
<tr>
<td valign="top" align="center">Log.sigma.4.mm.3D</td>
<td valign="top" align="center">Firstorder</td>
<td valign="top" align="center">90Percentile</td>
<td valign="top" align="center">-0.012</td>
</tr>
<tr>
<td valign="top" align="center">Log.sigma.5.mm.3D</td>
<td valign="top" align="center">Firstorder</td>
<td valign="top" align="center">90Percentile</td>
<td valign="top" align="center">-0.001</td>
</tr>
<tr>
<td valign="top" align="center">Squareroot</td>
<td valign="top" align="center">GLSZM</td>
<td valign="top" align="center">LargeAreaEmphasis</td>
<td valign="top" align="center">9.721*10<sup>-11</sup>
</td>
</tr>
<tr>
<td valign="top" align="center">Wavelet.LLL</td>
<td valign="top" align="center">GLDM</td>
<td valign="top" align="center">DependenceEntropy</td>
<td valign="top" align="center">0.001</td>
</tr>
<tr>
<td valign="top" align="center">Original</td>
<td valign="top" align="center">Shape</td>
<td valign="top" align="center">Maximum3DDiameter</td>
<td valign="top" align="center">0.003</td>
</tr>
<tr>
<td valign="top" align="center">Wavelet.HHL</td>
<td valign="top" align="center">GLRLM</td>
<td valign="top" align="center">LongRunLowGrayLevelEmphasis</td>
<td valign="top" align="center">0.006</td>
</tr>
<tr>
<td valign="top" align="center">Wavelet.HLL</td>
<td valign="top" align="center">GLRLM</td>
<td valign="top" align="center">LongRunLowGrayLevelEmphasis</td>
<td valign="top" align="center">0.011</td>
</tr>
<tr>
<td valign="top" align="center">Logarithm</td>
<td valign="top" align="center">Firstorder</td>
<td valign="top" align="center">InterquartileRange</td>
<td valign="top" align="center">0.014</td>
</tr>
<tr>
<td valign="top" align="center">Log.sigma.5.mm.3D</td>
<td valign="top" align="center">Firstorder</td>
<td valign="top" align="center">Kurtosis</td>
<td valign="top" align="center">0.022</td>
</tr>
<tr>
<td valign="top" align="center">Log.sigma.4.mm.3D</td>
<td valign="top" align="center">GLDM</td>
<td valign="top" align="center">LowGrayLevelEmphasis</td>
<td valign="top" align="center">0.031</td>
</tr>
<tr>
<td valign="top" align="center">Lbp.3d.k</td>
<td valign="top" align="center">GLDM</td>
<td valign="top" align="center">DependenceNonUniformityNormalized</td>
<td valign="top" align="center">0.714</td>
</tr>
<tr>
<td valign="top" align="center">Wavelet.HLH</td>
<td valign="top" align="center">GLCM</td>
<td valign="top" align="center">DifferenceEntropy</td>
<td valign="top" align="center">1.949</td>
</tr>
<tr>
<td valign="top" align="center">Wavelet.HLL</td>
<td valign="top" align="center">GLCM</td>
<td valign="top" align="center">Imc1</td>
<td valign="top" align="center">4.384</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Construction of clinical-radiomics machine learning models</title>
<p>The Rad-score calculated above was combined with clinical characteristics to construct CART, KNN, LASSO, NB, RF, SVM, and xGBoost models (<xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>). Additionally, we constructed a clinical model for comparison using stepwise logistic regression based on the clinical characteristics of the patients. All models demonstrated high predictive ability in the training set, with acceptable consistency in the validation and prospective sets (<xref ref-type="fig" rid="f3"><bold>Figures&#xa0;3A, B</bold></xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>The performance of machine learning models. (<bold>A</bold> Calibration curve of validation set; <bold>(B)</bold> Calibration curve of prospective set; <bold>(C)</bold> Receiver operating characteristic [ROC] curves of machine learning models in training set; <bold>(D)</bold> ROC curves of machine learning models in validation set; <bold>(E)</bold> ROC curves of machine learning models in prospective set; <bold>(F)</bold> decision curve analysis curves of machine learning models).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1265790-g003.tif"/>
</fig>
<p>A comprehensive evaluation of precision, F1 score, ROC curve, and AUC values in the training, validation, and prospective sets revealed that the RF model had a more stable predictive performance, followed by xGBoost and LASSO (<xref ref-type="fig" rid="f3"><bold>Figures&#xa0;3C&#x2013;E</bold></xref>). According to DCA, it is evident that xGBoost can significantly benefit patients (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3F</bold></xref>).</p>
<p>The SHAP value and SHAP plot were used to display the importance of each variable in the RF and xGBoost models. According to the SHAP, the variable importance of the two models is similar, and both can reflect that the Rad-score has the most significant impact. At the same time, other clinical characteristics such as Hemoglobin (Hb), age, Body Mass Index (BMI), gender, and diabetes mellitus also influenced the difficulty (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The SHAP plots of machine learning models. (<bold>A</bold> Random Forest; <bold>(B)</bold> Extreme Gradient Boosting).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1265790-g004.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>AT has become a hot topic in the medical field, and surgery is the primary treatment method. TPLA and RPLA were proposed in 1992 (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B23">23</xref>), respectively, and have continuously improved. The advantage of RPLA is that it results in less surgical trauma and bleeding, faster recovery, and fewer complications. Moreover, it is also suitable for some cases that traditional surgery finds challenging, such as obesity and complex AT. There are some relatively objective analysis systems for the surgical difficulty of TPLA, while there is less analysis on RPLA (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>This study retrospectively analyzed 396 patients who underwent RPLA for AT. The LASSO analysis of radiomics features was used to calculate the Rad-score. By combining the Rad-score with preoperative clinical characteristics, ML models such as CART, KNN, LASSO, NB, RF, SVM, and xGBoost were constructed and compared. It was found that RF had a more stable prediction accuracy, while xGBoost could bring more significant benefits to patients. The ML model suggested that in addition to the most influential Rad-score, the clinical characteristics such as Hb, age, BMI, gender, and diabetes mellitus also greatly influenced surgical difficulty. Through the validation of the validation set and prospective set, it was found that the ML models had high predictive ability. Through the comprehensive comparison of different models, it was found that the RF model exhibits the best prediction performance, thus making it our recommended model. Furthermore, in comparison to clinical models in previous study (<xref ref-type="bibr" rid="B16">16</xref>), our RF model exhibited superiority as evidenced by 2000 Bootstrap tests (D = 7.155, P &lt; 0.001). The discrimination power of models can be effectively compared using two measures: the Net Classification Index (NRI) and the Integrated Discrimination Improvement (IDI). In comparison to previous studies, the RF model in this study demonstrated an NRI of 0.308 (95% CI: 0.194-0.422, p &lt; 0.001) and an IDI of 0.165 (95% CI: 0.119-0.210, p &lt; 0.001).</p>
<p>The Rad-score calculated based on LASSO significantly impacts the surgical difficulty of RPLA. When performing univariate logistic regression, 279 features were statistically significant. After LASSO, 18 variables were retained and used to construct the Rad-score. The final retained variables included &#x201c;Shape Features&#x201d; like &#x201c;Maximum3DDiameter&#x201d;. Moreover, many studies have generally confirmed that the maximum diameter of the tumor is an essential factor affecting the difficulty of removing AT (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). In addition, &#x201c;First Order Features&#x201d;, which are linearly correlated with the CT value of the tumor, such as &#x201c;90Percentile&#x201d; were also included. Malignant and benign AT have different degrees of enhancement during arterial enhancement, which increases the risk of bleeding during surgery (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). It may also be because lipid-rich AT has lower CT values and requires more attention during surgery to prevent breaking the capsule, which prolongs the operation time (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B20">20</xref>). &#x201c;DifferenceEntropy&#x201d; in &#x201c;GLCM Features&#x201d; measures the randomness or complexity of differences between pixel intensity values. It was included because malignant tumors, such as metastases, exhibit more randomness or complexity between pixel intensity values, while their removal is more challenging than benign tumors (<xref ref-type="bibr" rid="B18">18</xref>).</p>
<p>Some clinical characteristics of patients also affect the difficulty of RPLA. Patients with diabetes mellitus are more likely to have perirenal fat adhesions, which affect surgical difficulty (<xref ref-type="bibr" rid="B26">26</xref>). Studies by Chen (<xref ref-type="bibr" rid="B17">17</xref>) and Takeda (<xref ref-type="bibr" rid="B27">27</xref>) have also shown that diabetes mellitus significantly affects it. Some studies also suggest that a history of hypertension and coronary heart disease affects surgical difficulty (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). BMI is used to assess the degree of obesity and also affects it. However, it mainly reflects the overall body fat composition, while the distribution of visceral fat, especially perirenal fat, may differ (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Therefore, there is still controversy over BMI prediction of surgical difficulty. Some studies believe that measuring visceral fat would be more accurate (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>Hb reflects the patient&#x2019;s blood reserve and blood oxygen reserve situation (<xref ref-type="bibr" rid="B30">30</xref>). If it is too low, it will affect the surgery. Age affects almost all tumor surgeries and prognoses because older patients often have poorer nutrition and tolerance. Moreover, diseases tend to be more malignant in older patients (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). In addition, some researchers believe that males may have more dangerous lifestyles (such as smoking), and there are differences in hormone levels between men and women, which may lead to poorer physical conditions and more incredible surgical difficulty in male patients (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>).</p>
<p>This study established ML models for predicting the difficulty of RPLA based on preoperative radiomics and clinical characteristics. It was validated internally and prospectively to prove that the ML models can significantly improve patients&#x2019; net benefit rate.</p>
<p>There needs to be more accurate prediction models for the difficulty of RPLA. The innovation of this study lies in combining ML with radiomics to analyze the risk factors for the difficulty of RPLA and establish prediction models for it, then conduct internal validation and prospective validation to make the model more meaningful. Moreover, this study is currently one of the largest cohorts using radiomics to predict the difficulty of RPLA.</p>
<p>The prospects of this study include: external validation to confirm its stability and accuracy further; using radiomics to analyze the tumor&#x2019;s surrounding environment while analyzing AT and optimizing the model through more ML algorithms. Some studies have proposed that magnetic resonance imaging has multiple weighted sequences, which may have better effects when applied to radiomics than CT. Although the accuracy of this study&#x2019;s models is high, the time cost of drawing ROI is high. If further promotion or clinical transformation is needed, combining deep learning to train artificial intelligence to draw ROI is necessary. Some studies have successfully trained artificial intelligence to draw ROIs for pancreatic duct tumors and predicted lymph node metastasis and prognosis based on them. Its sensitivity and specificity are superior to clinical and radiomics models (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<p>In conclusion, Rad-score, Hb, age, BMI, gender, and diabetes mellitus affect RPLA surgical difficulty. The ML prediction model established based on patient clinical characteristics and Rad-score using RF and xGBoost has good predictive performance. Through the above model, surgeons can effectively evaluate the difficulty of RPLA, thereby reducing surgical risks and improving patient benefits.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Ethics Committee of the Shanxi Bethune Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with the national legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>SS: Conceptualization, Data curation, Methodology, Project administration, Validation, Visualization, Writing &#x2013; original draft. WY: Data curation, Validation, Visualization, Writing &#x2013; original draft. YW: Data curation, Validation, Writing &#x2013; original draft. PY: Data curation, Writing &#x2013; original draft. FG: Data curation, Writing &#x2013; original draft. XD: Data curation, Writing &#x2013; original draft. YZ: Conceptualization, Methodology, Project administration, Supervision, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2023.1265790/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2023.1265790/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>AT, Adrenal tumor; ANOVA, Analysis of variance; AUC, Area under the curve; BMI, Body Mass Index; CART, Classification and Regression Trees; CT, Computed Tomography; DCA, Decision curve analysis; DICOM, Digital Imaging and Communications in Medicine; xGBoost, EXtreme Gradient Boosting; GLCM, Gray Level Co-occurrence Matrix; GLDM, Gray Level Dependence Matrix; GLRLM, Gray Level Run Length Matrix; GLSZM, Gray Level Size Zone Matrix; Hb, Hemoglobin; IDI, Integrated Discrimination Improvement; ICC, Intraclass correlation coefficient; KNN, K-Nearest Neighbors; LASSO, Least Absolute Shrinkage and Selection Operator; ML, Machine learning; NB, Naive Bayes; NGTDM, Neighboring Gray Tone Difference Matrix; NRI, Net Classification Index; Rad-score, Radiomics scores; RF, Random Forest; ROC, Receiver operating characteristic; ROI, Region of interest; RPLA, Retroperitoneal laparoscopic adrenalectomy; SHAP, Shapley Additive exPlanations; SVM, Support Vector Machine; TPLA, Transperitoneal laparoscopic adrenalectomy</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname> <given-names>R</given-names>
</name>
<name>
<surname>Garratt</surname> <given-names>J</given-names>
</name>
<name>
<surname>Remer</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Navin</surname> <given-names>P</given-names>
</name>
<name>
<surname>Blake</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Taffel</surname> <given-names>MT</given-names>
</name>
<etal/>
</person-group>. <article-title>Adrenal neoplasms: lessons from adrenal multidisciplinary tumor boards</article-title>. <source>Radiographics</source> (<year>2023</year>) <volume>43</volume>(<issue>7</issue>):<elocation-id>e220191</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1148/rg.220191</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinelli</surname> <given-names>S</given-names>
</name>
<name>
<surname>Amore</surname> <given-names>F</given-names>
</name>
<name>
<surname>Canu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Maggi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rapizzi</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Tumour microenvironment in pheochromocytoma and paraganglioma</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2023</year>) <volume>14</volume>:<elocation-id>1137456</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2023.1137456</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pamporaki</surname> <given-names>C</given-names>
</name>
<name>
<surname>Berends</surname> <given-names>AMA</given-names>
</name>
<name>
<surname>Filippatos</surname> <given-names>A</given-names>
</name>
<name>
<surname>Prodanov</surname> <given-names>T</given-names>
</name>
<name>
<surname>Meuter</surname> <given-names>L</given-names>
</name>
<name>
<surname>Prejbisz</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Prediction of metastatic pheochromocytoma and paraganglioma: A machine learning modelling study using data from a cross-sectional cohort</article-title>. <source>Lancet Digit Health</source> (<year>2023</year>) <volume>5</volume>(<issue>9</issue>):<elocation-id>e551&#x2013;9</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2589-7500(23)00094-8</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reincke</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bancos</surname> <given-names>I</given-names>
</name>
<name>
<surname>Mulatero</surname> <given-names>P</given-names>
</name>
<name>
<surname>Scholl</surname> <given-names>UI</given-names>
</name>
<name>
<surname>Stowasser</surname> <given-names>M</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>TA</given-names>
</name>
</person-group>. <article-title>Diagnosis and treatment of primary aldosteronism</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2021</year>) <volume>9</volume>(<issue>12</issue>):<page-range>876&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2213-8587(21)00210-2</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zelinka</surname> <given-names>T</given-names>
</name>
<name>
<surname>Eisenhofer</surname> <given-names>G</given-names>
</name>
<name>
<surname>Pacak</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice</article-title>. <source>Stress</source> (<year>2007</year>) <volume>10</volume>(<issue>2</issue>):<fpage>195</fpage>&#x2013;<lpage>203</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10253890701395896</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Co-occurrence of pheochromocytoma and paraganglioma of the organ of zuckerkandl resected simultaneously by laparoscopy: A rare case report and literature review</article-title>. <source>J Int Med Res</source> (<year>2023</year>) <volume>51</volume>(<issue>3</issue>):<elocation-id>3000605231161211</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/03000605231161211</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaujoux</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mihai</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>joint working group of E, Ensat. European Society of Endocrine Surgeons (Eses) and European Network for the Study of Adrenal Tumours (Ensat) Recommendations for the Surgical Management of Adrenocortical Carcinoma</article-title>. <source>Br J Surg</source> (<year>2017</year>) <volume>104</volume>(<issue>4</issue>):<page-range>358&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/bjs.10414</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaur</surname> <given-names>DD</given-names>
</name>
</person-group>. <article-title>Laparoscopic operative retroperitoneoscopy: use of a new device</article-title>. <source>J Urol</source> (<year>1992</year>) <volume>148</volume>(<issue>4</issue>):<page-range>1137&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0022-5347(17)36842-8</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rah</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>WW</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>KW</given-names>
</name>
<name>
<surname>Koh</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>New predictive factors for prolonged operation time of laparoscopic posterior retroperitoneal adrenalectomy; retrospective cohort study</article-title>. <source>Int J Surg</source> (<year>2021</year>) <volume>94</volume>:<elocation-id>106113</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijsu.2021.106113</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alberici</surname> <given-names>L</given-names>
</name>
<name>
<surname>Paganini</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Ricci</surname> <given-names>C</given-names>
</name>
<name>
<surname>Balla</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ballarini</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ortenzi</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Development and validation of a preoperative "Difficulty score" for laparoscopic transabdominal adrenalectomy: A multicenter retrospective study</article-title>. <source>Surg Endosc</source> (<year>2022</year>) <volume>36</volume>(<issue>5</issue>):<page-range>3549&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00464-021-08678-6</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson-Weiss</surname> <given-names>C</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bizzo</surname> <given-names>BC</given-names>
</name>
<name>
<surname>Glazer</surname> <given-names>DI</given-names>
</name>
<name>
<surname>Bridge</surname> <given-names>CP</given-names>
</name>
<name>
<surname>Andriole</surname> <given-names>KP</given-names>
</name>
<etal/>
</person-group>. <article-title>Machine learning for adrenal gland segmentation and classification of normal and adrenal masses at ct</article-title>. <source>Radiology</source> (<year>2023</year>) <volume>306</volume>(<issue>2</issue>):<fpage>e220101</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1148/radiol.220101</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>F</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>HL</given-names>
</name>
<etal/>
</person-group>. <article-title>Computed tomography-based machine learning differentiates adrenal pheochromocytoma from lipid-poor adenoma</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>833413</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.833413</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunn</surname> <given-names>B</given-names>
</name>
<name>
<surname>Pierobon</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Automated classification of lung cancer subtypes using deep learning and ct-scan based radiomic analysis</article-title>. <source>Bioengineering (Basel)</source> (<year>2023</year>) <volume>10</volume>(<issue>6</issue>):<fpage>690</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/bioengineering10060690</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>The gap before real clinical application of imaging-based machine-learning and radiomic models for chemoradiation outcome prediction in esophageal cancer: A systematic review and meta-analysis</article-title>. <source>Int J Surg</source> (<year>2023</year>) <volume>109</volume>(<issue>8</issue>):<page-range>2451&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/JS9.0000000000000441</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>J</given-names>
</name>
<name>
<surname>Diao</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Development of a radiomics model to diagnose pheochromocytoma preoperatively: A multicenter study with prospective validation</article-title>. <source>J Transl Med</source> (<year>2022</year>) <volume>20</volume>(<issue>1</issue>):<fpage>31</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12967-022-03233-w</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Yue</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>A nomogram for evaluation and analysis of difficulty in retroperitoneal laparoscopic adrenalectomy: A single-center study with prospective validation using lasso-logistic regression</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>1004112</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.1004112</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Scholten</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chomsky-Higgins</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nwaogu</surname> <given-names>I</given-names>
</name>
<name>
<surname>Gosnell</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Seib</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Risk factors associated with perioperative complications and prolonged length of stay after laparoscopic adrenalectomy</article-title>. <source>JAMA Surg</source> (<year>2018</year>) <volume>153</volume>(<issue>11</issue>):<page-range>1036&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jamasurg.2018.2648</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Natkaniec</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dworak</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pedziwiatr</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pisarska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Major</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dembinski</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Patients criteria determining difficulty of the laparoscopic lateral transperitoneal adrenalectomy</article-title>. <source>A Retrospective Cohort Study. Int J Surg</source> (<year>2017</year>) <volume>43</volume>:<page-range>33&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijsu.2017.05.032</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Perioperative factors influencing the difficulty of retroperitoneal laparoscopic adrenalectomy: A single-center retrospective study</article-title>. <source>BMC Urol</source> (<year>2022</year>) <volume>22</volume>(<issue>1</issue>):<elocation-id>22</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12894-022-00976-y</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Mayo adhesive probability score is associated with perioperative outcomes in retroperitoneal laparoscopic adrenalectomy</article-title>. <source>ANZ J Surg</source> (<year>2022</year>) <volume>92</volume>(<issue>12</issue>):<page-range>3273&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ans.17983</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clavien</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Barkun</surname> <given-names>J</given-names>
</name>
<name>
<surname>de Oliveira</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Vauthey</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Dindo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Schulick</surname> <given-names>RD</given-names>
</name>
<etal/>
</person-group>. <article-title>The clavien-dindo classification of surgical complications: five-year experience</article-title>. <source>Ann Surg</source> (<year>2009</year>) <volume>250</volume>(<issue>2</issue>):<page-range>187&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/SLA.0b013e3181b13ca2</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundberg</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Erion</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>DeGrave</surname> <given-names>A</given-names>
</name>
<name>
<surname>Prutkin</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Nair</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>From local explanations to global understanding with explainable ai for trees</article-title>. <source>Nat Mach Intell</source> (<year>2020</year>) <volume>2</volume>(<issue>1</issue>):<fpage>56</fpage>&#x2013;<lpage>67</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42256-019-0138-9</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gagner</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lacroix</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bolte</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Laparoscopic adrenalectomy in cushing's syndrome and pheochromocytoma</article-title>. <source>N Engl J Med</source> (<year>1992</year>) <volume>327</volume>(<issue>14</issue>):<fpage>1033</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJM199210013271417</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pisarska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dworak</surname> <given-names>J</given-names>
</name>
<name>
<surname>Natkaniec</surname> <given-names>M</given-names>
</name>
<name>
<surname>Malczak</surname> <given-names>P</given-names>
</name>
<name>
<surname>Przeczek</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wysocki</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Risk factors for prolonged hospitalization in patients undergoing laparoscopic adrenalectomy</article-title>. <source>Wideochir Inne Tech Maloinwazyjne</source> (<year>2018</year>) <volume>13</volume>(<issue>2</issue>):<page-range>141&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.5114/wiitm.2018.73357</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidal</surname> <given-names>O</given-names>
</name>
<name>
<surname>Saavedra-Perez</surname> <given-names>D</given-names>
</name>
<name>
<surname>Martos</surname> <given-names>JM</given-names>
</name>
<name>
<surname>de la Quintana</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rodriguez</surname> <given-names>JI</given-names>
</name>
<name>
<surname>Villar</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Risk factors for open conversion of lateral transperitoneal laparoscopic adrenalectomy: retrospective cohort study of the spanish adrenal surgery group (Sasg)</article-title>. <source>Surg Endosc</source> (<year>2020</year>) <volume>34</volume>(<issue>8</issue>):<page-range>3690&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00464-019-07264-1</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yanishi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kinoshita</surname> <given-names>H</given-names>
</name>
<name>
<surname>Koito</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Taniguchi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mishima</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sugi</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Adherent perinephric fat is a surgical risk factor in laparoscopic single-site donor nephrectomy: analysis using mayo adhesive probability score</article-title>. <source>Transplant Proc</source> (<year>2020</year>) <volume>52</volume>(<issue>1</issue>):<page-range>84&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.transproceed.2019.11.027</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeda</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hakozaki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yanai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Masuda</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yasumizu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Risk factors for haemodynamic instability and its prolongation during laparoscopic adrenalectomy for pheochromocytoma</article-title>. <source>Clin Endocrinol (Oxf)</source> (<year>2021</year>) <volume>95</volume>(<issue>5</issue>):<page-range>716&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cen.14557</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunaud</surname> <given-names>L</given-names>
</name>
<name>
<surname>Nguyen-Thi</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Mirallie</surname> <given-names>E</given-names>
</name>
<name>
<surname>Raffaelli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vriens</surname> <given-names>M</given-names>
</name>
<name>
<surname>Theveniaud</surname> <given-names>PE</given-names>
</name>
<etal/>
</person-group>. <article-title>Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: A multicenter retrospective analysis in 225 patients</article-title>. <source>Surg Endosc</source> (<year>2016</year>) <volume>30</volume>(<issue>3</issue>):<page-range>1051&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00464-015-4294-7</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>BiLiGe</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Min</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Predicting factors related with uncured hypertension after retroperitoneal laparoscopic adrenalectomy for unilateral primary aldosteronism</article-title>. <source>Med (Baltimore)</source> (<year>2019</year>) <volume>98</volume>(<issue>30</issue>):<fpage>e16611</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MD.0000000000016611</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Premont</surname> <given-names>RT</given-names>
</name>
<name>
<surname>Reynolds</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Stamler</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Role of nitric oxide carried by hemoglobin in cardiovascular physiology: developments on a three-gas respiratory cycle</article-title>. <source>Circ Res</source> (<year>2020</year>) <volume>126</volume>(<issue>1</issue>):<page-range>129&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.119.315626</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Fidler-Benaoudia</surname> <given-names>M</given-names>
</name>
<name>
<surname>Keegan</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Hipp</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Jemal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Siegel</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>Cancer statistics for adolescents and young adults, 2020</article-title>. <source>CA Cancer J Clin</source> (<year>2020</year>) <volume>70</volume>(<issue>6</issue>):<page-range>443&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21637</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>L</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019</article-title>. <source>J Hematol Oncol</source> (<year>2021</year>) <volume>14</volume>(<issue>1</issue>):<fpage>197</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13045-021-01213-z</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Lanca de Oliveira</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cruz</surname> <given-names>I</given-names>
</name>
<name>
<surname>Goncalves</surname> <given-names>I</given-names>
</name>
<name>
<surname>Cascalheira</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>CRA</given-names>
</name>
</person-group>. <article-title>The sex bias of cancer</article-title>. <source>Trends Endocrinol Metab</source> (<year>2020</year>) <volume>31</volume>(<issue>10</issue>):<page-range>785&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tem.2020.07.002</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haupt</surname> <given-names>S</given-names>
</name>
<name>
<surname>Caramia</surname> <given-names>F</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Rubin</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Haupt</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Sex disparities matter in cancer development and therapy</article-title>. <source>Nat Rev Cancer</source> (<year>2021</year>) <volume>21</volume>(<issue>6</issue>):<fpage>393</fpage>&#x2013;<lpage>407</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41568-021-00348-y</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Fishman</surname> <given-names>EK</given-names>
</name>
</person-group>. <article-title>Artificial intelligence outperforms radiologists for pancreatic cancer lymph node metastasis prediction at ct</article-title>. <source>Radiology</source> (<year>2023</year>) <volume>306</volume>(<issue>1</issue>):<page-range>170&#x2013;1</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1148/radiol.222012</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>
